TITLE

Stress on pleiotropic effects of statins

AUTHOR(S)
Mishra, Pankaj Kumar
PUB. DATE
May 2006
SOURCE
European Journal of Cardio-Thoracic Surgery;May2006, Vol. 29 Issue 5, p861
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
20623266

 

Related Articles

  • Pleiotropic Effects of Statins: Implications for a Wide Range of Diseases. Paraskevas, Kosmas I.; Stathopoulos, Vassilios; Mikhailidis, Dimitri P. // Current Vascular Pharmacology;Oct2008, Vol. 6 Issue 4, p237 

    The article discusses the implications of the pleiotropic effects of statins for a wide range of diseases. It notes that statins, which are designed to prevent cholesterol biosynthesis, are effective and safe with the exception of Cerivastatin, which caused rhabdomyolysis. It mentions that...

  • Pleiotropic effects of statins in the perioperative setting. Galyfos, George; Sianou, Argyri; Filis, Konstantinos // Annals of Cardiac Anaesthesia;2017 Special Issue 1, Vol. 20, pS43 

    Statins belong to a specific group of drugs that have been described for their ability to control hyperlipidemia as well as for other pleiotropic effects such as improving vascular endothelial function, inhibition of oxidative stress pathways, and anti-inflammatory actions. Accumulating clinical...

  • Can Statin be a Novel Pharmacophore for Antidiabetic Activity? Parmar, S. A.; Mehta, A. A. // Mini Reviews in Medicinal Chemistry;Oct2009, Vol. 9 Issue 12, p1423 

    Currently, statins are in lime light due to their pleiotropic effects. One of their pleiotropic effects is on glucose metabolism. Various clinical and preclinical studies were designed to evaluate statins' effect on glucose metabolism. This review describes preclinical and clinical evidences of...

  • Pleiotropic effects of HMG-CoA reductase inhibitors. Werner, Nikos; Nickenig, Georg; Laufs, Ulrich // Basic Research in Cardiology;Mar2002, Vol. 97 Issue 2, p105 

    HMG CoA reductase inhibitiors (statins) have been shown to be effective lipid lowering agents and are able to significantly reduce cardiovascular mortality and morbidity in patients at risk for cardiovascular disease. Recent clinical and experimental data suggest that the benefit of statins may...

  • Endothelial Dysfunction, Oxidative Stress and Inflammation in Atherosclerosis: Beneficial Effects of Statins. Lahera, Vicente; Goicoechea, Marian; García de Vinuesa, Soledad; Miana, María; Heras, Natalia de las; Cachofeiro, Victoria; Luño, José // Current Medicinal Chemistry;2007, Vol. 14 Issue 2, p243 

    Atherosclerosis and its complications represent the major cause of death in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A [HMGCoA] reductase and consequently inhibitors of cholesterol biosynthesis. Statins have been described as the most potent class of...

  • Pleiotropic Effects of Statins - Clinical Evidence. Athyros, Vasilios G.; Kakafika, Anna I.; Tziomalos, Konstantinos; Karagiannis, Asterios; Mikhailidis, Dimitri P. // Current Pharmaceutical Design;2/11/2009, Vol. 15 Issue 5, p479 

    The present review considers the potential pleiotropic effects of statins and the evidence indicative of the "real world" benefit from these effects in patients with cardiovascular disease (CVD). Some of these cholesterol-independent effects of statins involve improved endothelial function,...

  • Statins and the autonomic nervous system. MILLAR, Philip J.; FLORAS, John S. // Clinical Science;Mar2014, Vol. 126 Issue 6, p401 

    Statins (3-hydroxy-3-methylglutaryl-CoA reductase inhibitors) reduce plasma cholesterol and improve endothelium-dependent vasodilation, inflammation and oxidative stress. A 'pleiotropic' property of statins receiving less attention is their effect on the autonomic nervous system. Increased...

  • Pleiotropic Effects of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors: Candidate Mechanisms for Anti-Lipid Deposition in Blood Vessels. Kumai, T.; Matsumoto, N.; Koitabashi, Y.; Takeba, Y.; Oonuma, S.; Sekine, S.; Tadokoro, M.; Kobayashi, S. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Jul2005, Vol. 3 Issue 3, p195 

    The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) are considered first-line therapeutic agents for the prevention of coronary heart disease and atherosclerotic disorders related to hypercholesterolemia. Statins inhibit lipid deposition in the aortic endothelium. Although...

  • Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells. Tatsuro Minami; Kimio Satoh; Masamichi Nogi; Shun Kudo; Satoshi Miyata; Shin-ichi Tanaka; Hiroaki Shimokawa // Cardiovascular Research;Jan2016, Vol. 109 Issue 1, p151 

    Aims The pleiotropic effects of HMG-CoA reductase inhibitors (statins) independent of cholesterol-lowering effects have attracted much attention. We have recently demonstrated that the pleiotropic effects of statins are partly mediated through up-regulation of small GTP-binding protein...

  • Statins: Do They Have Beneficial Effects Over and Above Their Actions on Lipids? Gotto Jr., Antonio; LaRosa, John; Reiffel, James // Medical Roundtable: Cardiovascular Edition;Spring2010, Vol. 1 Issue 2, p73 

    The discussion focused primarily on: (1) possible additional benefits, or pleiotropic effects, of statins beyond statin monotherapy's primary effect to reduce LDL cholesterol, (2) the results of the clinical trial JUPITER and the use of statins for prevention, (3) the use of CRP as a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics